PANCREAZE
Drug
VIVUS, Inc.
Total Payments
$635,434
Transactions
5,740
Doctors
2,050
Companies
3
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $101,534 | 1,412 | 787 |
| 2023 | $28,177 | 880 | 507 |
| 2022 | $88,825 | 1,150 | 635 |
| 2021 | $94,714 | 4 | 0 |
| 2020 | $147,602 | 693 | 274 |
| 2019 | $77,509 | 1,052 | 541 |
| 2018 | $43,692 | 272 | 0 |
| 2017 | $53,381 | 277 | 2 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $459,315 | 963 | 72.3% |
| Food and Beverage | $89,043 | 4,731 | 14.0% |
| Charitable Contribution | $39,000 | 15 | 6.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $21,625 | 14 | 3.4% |
| Consulting Fee | $14,402 | 11 | 2.3% |
| Space rental or facility fees (teaching hospital only) | $12,050 | 6 | 1.9% |
Payments by Type
Research
$459,315
963 transactions
General
$176,119
4,777 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| IIT - Pancreaze Enzyme Replenishment Therapy | VIVUS LLC | $200,897 | 0 |
| A Long-Term Prospective Observational Safety Study of the Incidence of and Risk Factors for Fibrosing Colonopathy in US Patients with Cystic Fibrosis Treated with Pancreatic Enzyme Replacement | Janssen Research & Development, LLC | $80,621 | 2 |
| Long-term Study in US Cystic Fibrosis | VIVUS, Inc. | $76,406 | 0 |
| IIT - Pancreaze Enzyme Replenishment Therapy | VIVUS, Inc. | $61,142 | 0 |
| Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms | VIVUS, Inc. | $40,248 | 0 |
Top Doctors Receiving Payments for PANCREAZE — Page 2
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , MD | Gastroenterology | Clermont, FL | $308.71 | 15 |
| , NP | Family | Palmer, MA | $293.87 | 14 |
| , M.D | Gastroenterology | Charlotte, NC | $286.92 | 16 |
| , D.O | Gastroenterology | Largo, FL | $263.07 | 16 |
| , MD | Internal Medicine | Los Angeles, CA | $262.64 | 8 |
| , DO | Internal Medicine | Rosemead, CA | $262.48 | 3 |
| , ARNP | Adult Health | Orlando, FL | $261.64 | 13 |
| , M.D.,PH.D | Family Medicine | Alhambra, CA | $257.02 | 8 |
| , M.D | Gastroenterology | Sarasota, FL | $253.35 | 12 |
| , M.D | Gastroenterology | Monterey Park, CA | $244.99 | 2 |
| , M.D | Family Medicine | Alhambra, CA | $244.99 | 2 |
| , APRN | Family | Largo, FL | $242.99 | 15 |
| , P.A.-C | Medical | Largo, FL | $242.99 | 15 |
| , M.D | Family Medicine | San Gabriel, CA | $242.31 | 7 |
| , M.D | Gastroenterology | Valparaiso, IN | $241.81 | 14 |
| , M.D | Gastroenterology | Bourbonnais, IL | $240.35 | 14 |
| , MD | Gastroenterology | Davidson, NC | $238.83 | 14 |
| , M.D | Gastroenterology | Brooklyn, NY | $237.89 | 12 |
| , M.D | Family Medicine | Monterey Park, CA | $236.17 | 7 |
| , MD | Gastroenterology | Ocoee, FL | $231.42 | 12 |
| , M.D | Internal Medicine | Alhambra, CA | $225.31 | 11 |
| , M.D | Internal Medicine | Brooklyn, NY | $221.29 | 10 |
| , D.O | Gastroenterology | Brooklyn, NY | $220.65 | 12 |
| , APRN | Nurse Practitioner | Ocoee, FL | $214.07 | 11 |
| Jia Huang | Adult Health | Brooklyn, NY | $210.37 | 11 |
Ad
Manufacturing Companies
- VIVUS LLC $313,250
- VIVUS, Inc. $241,563
- Janssen Research & Development, LLC $80,621
Product Information
- Type Drug
- Total Payments $635,434
- Total Doctors 2,050
- Transactions 5,740
About PANCREAZE
PANCREAZE is a drug associated with $635,434 in payments to 2,050 healthcare providers, recorded across 5,740 transactions in the CMS Open Payments database. The primary manufacturer is VIVUS, Inc..
Payment data is available from 2017 to 2024. In 2024, $101,534 was paid across 1,412 transactions to 787 doctors.
The most common payment nature for PANCREAZE is "Unspecified" ($459,315, 72.3% of total).
PANCREAZE is associated with 5 research studies, including "IIT - Pancreaze Enzyme Replenishment Therapy" ($200,897).